Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A SARS-CoV-2 lineage A variant (A.23.1) with altered spike has emerged and is dominating the current Uganda epidemic

Daniel Lule Bugembe, My V.T. Phan, Isaac Ssewanyana, Patrick Semanda, Hellen Nansumba, Beatrice Dhaala, Susan Nabadda, Áine Niamh O’Toole, Andrew Rambaut, Pontiano Kaleebu, View ORCID ProfileMatthew Cotten
doi: https://doi.org/10.1101/2021.02.08.21251393
Daniel Lule Bugembe
1MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
My V.T. Phan
1MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda
5EMC, Rotterdam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isaac Ssewanyana
2Central Public Health Laboratories of the Republic of Uganda, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Semanda
2Central Public Health Laboratories of the Republic of Uganda, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hellen Nansumba
2Central Public Health Laboratories of the Republic of Uganda, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatrice Dhaala
1MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Nabadda
2Central Public Health Laboratories of the Republic of Uganda, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Áine Niamh O’Toole
3Institute for Evolutionary Biology, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Rambaut
3Institute for Evolutionary Biology, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pontiano Kaleebu
1MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda
4Uganda Virus Research Institute, Entebbe, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Cotten
1MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda
6MRC-University of Glasgow Centre for Virus Research, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew Cotten
  • For correspondence: Matthew.Cotten@lshtm.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first detected in March 2020 in Uganda. Recently the epidemic showed a shift of SARS-CoV-2 variant distribution and we report here newly emerging A sub-lineages, A.23 and A.23.1, encoding replacements in the spike protein, nsp6, ORF8 and ORF9, with A.23.1 the major virus lineage now observed in Kampala. Although the clinical impact of the A.23.1 variant is not yet clear it is essential to continue careful monitoring of this variant, as well as rapid assessment of the consequences of the spike protein changes for vaccine efficacy.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The SARS-CoV2 diagnostic and sequencing award is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (grant agreement number NC_PC_19060) and is also part of the EDCTP2 programme supported by the European Union. The UMIC high performance computer was supported by MRC (grant number MC_EX_MR/L016273/1) to PK. A.R. acknowledges the support of the Wellcome Trust (Collaborators Award 206298/Z/17/Z ARTIC network) and the European Research Council (grant agreement no. 725422 ReservoirDOCS). The study is additionally funded by the Wellcome, DFID Wellcome Epidemic Preparedness Coronavirus (grant agreement number 220977/Z/20/Z) awarded to MC.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Uganda Virus Research Institute- Research and Ethics Committee (UVRI-REC Federalwide Assurance [FWA] FWA No. 00001354, study reference. GC/127/20/04/771) and by the Uganda National Council for Science and Technology, reference number HS936ES.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The novel reported SARS-CoV-2 genomes are available on GISAID (https://www.gisaid.org/) under the accession numbers EPI_ISL_954226-EPI_ISL_954300 and EPI_ISL_955136.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted February 11, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A SARS-CoV-2 lineage A variant (A.23.1) with altered spike has emerged and is dominating the current Uganda epidemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A SARS-CoV-2 lineage A variant (A.23.1) with altered spike has emerged and is dominating the current Uganda epidemic
Daniel Lule Bugembe, My V.T. Phan, Isaac Ssewanyana, Patrick Semanda, Hellen Nansumba, Beatrice Dhaala, Susan Nabadda, Áine Niamh O’Toole, Andrew Rambaut, Pontiano Kaleebu, Matthew Cotten
medRxiv 2021.02.08.21251393; doi: https://doi.org/10.1101/2021.02.08.21251393
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A SARS-CoV-2 lineage A variant (A.23.1) with altered spike has emerged and is dominating the current Uganda epidemic
Daniel Lule Bugembe, My V.T. Phan, Isaac Ssewanyana, Patrick Semanda, Hellen Nansumba, Beatrice Dhaala, Susan Nabadda, Áine Niamh O’Toole, Andrew Rambaut, Pontiano Kaleebu, Matthew Cotten
medRxiv 2021.02.08.21251393; doi: https://doi.org/10.1101/2021.02.08.21251393

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5219)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (750)
  • Geriatric Medicine (77)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (223)
  • Hematology (98)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5823)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (94)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (854)
  • Public and Global Health (1994)
  • Radiology and Imaging (345)
  • Rehabilitation Medicine and Physical Therapy (157)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)